QC
LENZ

Quadrature Capital’s LENZ Therapeutics LENZ Stock Holding History

Quadrature Capital’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
+49,132
New +$396K ﹤0.01% 1231

Other funds holding LENZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

Quadrature Capital's LENZ Position: Q2 2026 in Review

Quadrature Capital opened a new position in LENZ Therapeutics (LENZ) in Q2 2026: 49,132 shares worth $279K. The stake represents ﹤0.01% of the portfolio and ranks #1231 among its holdings.

40 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Quadrature Capital held 49,132 shares of LENZ Therapeutics worth $279K as of Q2 2026.
  • LENZ Therapeutics was a new Quadrature Capital position in Q2 2026.
  • LENZ Therapeutics made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1231 holding.
  • 40 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.